Jim Simons Annexon, Inc. Transaction History
Renaissance Technologies LLC
- $70.6 Billion
- Q2 2025
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Annexon, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 777,900 shares of ANNX stock, worth $1.9 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
777,900
Previous 1,162,437
33.08%
Holding current value
$1.9 Million
Previous $2.24 Million
16.81%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding ANNX
# of Institutions
136Shares Held
96.3MCall Options Held
0Put Options Held
63.4K-
Satter Management Co., L.P.7.41MShares$18.1 Million71.99% of portfolio
-
Bvf Inc San Francisco, CA7MShares$17.1 Million0.66% of portfolio
-
Black Rock Inc. New York, NY6.59MShares$16.1 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA6.3MShares$15.4 Million1.84% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.37MShares$13.1 Million0.0% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $116M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...